Antibody Drug Conjugation

As a pioneer in GMP manufacturing of antibody drug conjugate products we have a wealth of experience, from proof of concept studies to scale up and commercial supplies. Our facility in Scotland is dedicated to process development, scale up and manufacturing of bioconjugates with a primary focus on ADCs.

For more than a decade, we have partnered with leading ADC technology companies and their licensees to develop robust processes used in pre-clinical, clinical and commercial supplies. We have made over 460 batches (>240 GMP batches) of ADCs spanning more than 60 distinct ADC candidates.